Crossbeta Biosciences B.V.

Crossbeta Biosciences is a biotech company that has developed an innovative technology to generate stable oligomers for drug discovery and development in disease areas characterized by the presence of misfolded proteins, such as Alzheimer’s, Parkinson’s, Huntington’s disease and ALS. Crossbeta’s unique stable oligomers maintain their biopathological properties for the screening of oligomer-specific therapeutics and for the development of biomarker and diagnostic assays.